Search
forResearch 10 of 1000+
- The Alopecia Areata Severity and Morbidity Index (ASAMI) Study
- Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast
- Assessment of Alopecia Areata Disease Severity in Pediatric Patients
- Assessment of prognostic markers of alopecia areata in pediatric patients
- Upadacitinib for the Treatment of Systemic Immune Co-Morbidity in One Case: Alopecia Areata, Vitiligo, Ankylosing Spondylitis, and Allergic Rhinitis-Asthma – Multifaceted Control
- Complete Blood Collection-based Systemic Inflammation Biomarkers as a Severity Biomarker in Alopecia Areata: A Cross-sectional Study
- Increased serum interleukin-17A levels correlate with disease severity and poor prognostic factors in patients with alopecia areata
- 15. Hair and Nails
- Assessment of Interleukin-17A and Interleukin-2 Serum Levels in Patients with Alopecia Areata
- Skin
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →